OTCQB:BTCY

24/7 MarketNews›Press Releases›OTCQB:BTCY

Venture Breakfast Bits, by 24/7 Market News

Venture Market News for January 11, 2019 Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared Excellagen® Wound Conforming Gel Matrix with Three Read More

Ben Hansel 2019-01-11T09:29:33+00:00 Jan. 11, 2019 9:25AM EDT|

Send this to a friend

Your emailRecipient email18+6

Hi, this may be interesting you: Venture Breakfast Bits, by 24/7 Market News! This is the link: https://www.247marketnews.com/press-releases/venture-breakfast-bits-by-24-7-market-news-95/